Vimarsana
Biggest News Aggregation in the World

Innovator Network News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Innovator Network. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Innovator Network Today - Breaking & Trending Today

UpDoc to develop conversational, assistant-directed AI providers - Vimarsana News

UpDoc to develop conversational, assistant-directed AI providers

Microsoft, Google, the Santa Clara County Independent Physician Association, UCSF Health, Mayo Clinic and the American Heart Association are partnering with the company to put clinically managed artificial intelligence providers in patient homes.

H|T: The Healthtech Times – SmileDirectClub shuts down shortly after declaring bankruptcy - Vimarsana News

H|T: The Healthtech Times – SmileDirectClub shuts down shortly after declaring bankruptcy

The Healthtech Times is a weekly newsletter covering healthtech news from Canada and around the globe.

Montréal's tech hub is in trouble, Waterloo Region goes grassroots - Vimarsana News

Montréal's tech hub is in trouble, Waterloo Region goes grassroots

Welcome to BetaKit's startup stories of the week! Here, you will find the week's most important news, features, and editorials published on BetaKit.

Kitchener-Waterloo tech leaders launch new community-building platform Waterloo Inc. - Vimarsana News

Kitchener-Waterloo tech leaders launch new community-building platform Waterloo Inc.

Kitchener-Waterloo tech leaders have teamed up to found Waterloo Inc, a new platform for local community-building and discussions about the innovation economy.

Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023 Scientific Sessions - Vimarsana News

Partners Announce TRANSFORM Trial to Evaluate Personalized Heart Disease Care Strategies at American Heart Association 2023 Scientific Sessions

An announcement on partners to collaborate in the TRANSFORM trial was made today during the American Heart Association’s (AHA) 2023 Scientific Sessions. Data from the randomized control trial will advance evidence for evaluation and treatment of heart disease by studying actual disease: atherosclerosis.